14 February, 2022

PAGE ONE is going to make a complete diagnosis of the declared financing between pharmaceutical companies and medical societies, digging into Infarmed’s Transparency and Publicity database, a platform that should be easy to read and consult, but which has its nuances. This is the first of a series of articles that will dive deep into the promiscuous relationships between doctors and pharmaceutical companies. For now, learn how much you are talking about when you talk about money involved.